JP2022553826A5 - - Google Patents
Info
- Publication number
- JP2022553826A5 JP2022553826A5 JP2022525813A JP2022525813A JP2022553826A5 JP 2022553826 A5 JP2022553826 A5 JP 2022553826A5 JP 2022525813 A JP2022525813 A JP 2022525813A JP 2022525813 A JP2022525813 A JP 2022525813A JP 2022553826 A5 JP2022553826 A5 JP 2022553826A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024005177A JP2024056696A (ja) | 2019-11-05 | 2024-01-17 | 二重ｉｌ－２ｒおよびｉｌ－７ｒ結合化合物 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962930758P | 2019-11-05 | 2019-11-05 | |
| US62/930,758 | 2019-11-05 | ||
| US202062969432P | 2020-02-03 | 2020-02-03 | |
| US62/969,432 | 2020-02-03 | ||
| US202063041158P | 2020-06-19 | 2020-06-19 | |
| US63/041,158 | 2020-06-19 | ||
| US202063071946P | 2020-08-28 | 2020-08-28 | |
| US63/071,946 | 2020-08-28 | ||
| PCT/US2020/058969 WO2021092081A1 (en) | 2019-11-05 | 2020-11-04 | Dual il-2r and il-7r binding compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024005177A Division JP2024056696A (ja) | 2019-11-05 | 2024-01-17 | 二重ｉｌ－２ｒおよびｉｌ－７ｒ結合化合物 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022553826A JP2022553826A (ja) | 2022-12-26 |
| JP2022553826A5 true JP2022553826A5 (https=) | 2023-04-19 |
| JPWO2021092081A5 JPWO2021092081A5 (https=) | 2023-04-19 |
| JP7427287B2 JP7427287B2 (ja) | 2024-02-05 |
Family
ID=75686972
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525813A Active JP7427287B2 (ja) | 2019-11-05 | 2020-11-04 | 二重ｉｌ－２ｒおよびｉｌ－７ｒ結合化合物 |
| JP2024005177A Withdrawn JP2024056696A (ja) | 2019-11-05 | 2024-01-17 | 二重ｉｌ－２ｒおよびｉｌ－７ｒ結合化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024005177A Withdrawn JP2024056696A (ja) | 2019-11-05 | 2024-01-17 | 二重ｉｌ－２ｒおよびｉｌ－７ｒ結合化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11248030B2 (https=) |
| EP (1) | EP4055036A4 (https=) |
| JP (2) | JP7427287B2 (https=) |
| KR (1) | KR20220110209A (https=) |
| AU (2) | AU2020378282B2 (https=) |
| BR (1) | BR112022008750A2 (https=) |
| CA (1) | CA3160466A1 (https=) |
| IL (1) | IL292803A (https=) |
| MX (1) | MX2022005404A (https=) |
| TW (1) | TW202132330A (https=) |
| WO (1) | WO2021092081A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021201047B2 (en) * | 2018-08-06 | 2022-02-17 | Medikine, Inc. | Il-2 receptor binding compounds |
| MX2021001493A (es) | 2018-08-06 | 2021-07-15 | Medikine Inc | Compuestos de fijación al receptor de il-2. |
| KR20220110207A (ko) * | 2019-11-05 | 2022-08-05 | 메디카인 인코포레이티드 | IL-2RβγC 결합 화합물 |
| MX2022005404A (es) * | 2019-11-05 | 2022-09-09 | Medikine Inc | Compuestos de fijación a il-2r e il-7r dual. |
| IL295304A (en) * | 2020-02-03 | 2022-10-01 | Medikine Inc | Il-7 receptor alpha gamma c binding compounds, compositions comprising same and uses thereof |
| KR20230097168A (ko) * | 2020-11-04 | 2023-06-30 | 메디카인 인코포레이티드 | IL-2Rβγc 결합 화합물 및 이의 용도 |
| WO2023133595A2 (en) | 2022-01-10 | 2023-07-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| US20250222027A1 (en) | 2022-04-01 | 2025-07-10 | Sana Biotechnology, Inc. | Cytokine receptor agonist and viral vector combination therapies |
| US11999771B2 (en) * | 2022-04-07 | 2024-06-04 | Medikine, Inc. | IL-7Rαγc ligand immunoglobulin fusion proteins |
| WO2024054870A1 (en) * | 2022-09-06 | 2024-03-14 | Medikine, Inc. | Use of il-7r-alpha-gamma agonist peptides in cell manufacturing |
| US20240101959A1 (en) * | 2022-09-06 | 2024-03-28 | Medikine, Inc. | Use of il-2r-beta-gamma agonist peptides in cell manufacturing |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635597A (en) * | 1994-05-27 | 1997-06-03 | Affymax Technologies, N.V. | Peptides that bind IL-2 receptors |
| PT1454138E (pt) * | 2001-12-04 | 2012-03-28 | Merck Patent Gmbh | Imunocitoquinas com seletividade modulada |
| DK1648931T3 (da) * | 2003-07-21 | 2011-03-07 | Transgene Sa | Multifunktionelle cytokiner |
| CA2551915C (en) | 2003-12-30 | 2015-06-23 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Il-7 fusion proteins |
| WO2010099084A2 (en) | 2009-02-27 | 2010-09-02 | Monsanto Technology Llc | Isolated novel nucleic acid and protein molecules from corn and methods of using those molecules |
| ES2866674T3 (es) | 2010-11-12 | 2021-10-19 | Nektar Therapeutics | Conjugados de una fracción de IL-2 y un polímero |
| US9266937B2 (en) | 2010-12-10 | 2016-02-23 | University Of Central Florida Research Foundation, Inc. | Compositions comprising IL-7 receptor ligands |
| HRP20200470T1 (hr) | 2011-01-18 | 2020-10-02 | Bioniz, Llc | Pripravci za modulaciju aktivnosti gama-c-citokina |
| CN102775496B (zh) * | 2011-05-13 | 2014-10-08 | 中国医学科学院基础医学研究所 | 靶向清除hiv/siv的复合药物 |
| WO2015164815A1 (en) | 2014-04-24 | 2015-10-29 | The Board Of Trustees Of The Leland Stanford Junior University | Superagonists, partial agonists and antagonists of interleukin-2 |
| GB2538666A (en) | 2014-07-21 | 2016-11-23 | Delinia Inc | Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases |
| WO2016025385A1 (en) | 2014-08-11 | 2016-02-18 | Delinia, Inc. | Modified il-2 variants that selectively activate regulatory t cells for the treatment of autoimmune diseases |
| PT3328894T (pt) | 2015-08-06 | 2019-02-13 | Agency Science Tech & Res | Anticorpos de cadeia comum gama/il2rbeta |
| US20170204154A1 (en) | 2016-01-20 | 2017-07-20 | Delinia, Inc. | Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseases |
| CA3011374A1 (en) | 2016-02-05 | 2017-08-10 | Washington University | Compositions and methods for targeted cytokine delivery |
| JP2019518786A (ja) * | 2016-05-06 | 2019-07-04 | 牧林 王 | インターロイキンの組み合せ及びその使用 |
| US11077172B2 (en) | 2016-11-08 | 2021-08-03 | Delinia, Inc. | IL-2 variants for the treatment of psoriasis |
| BR122020025384B1 (pt) | 2016-12-13 | 2022-07-12 | Delinia, Inc | Proteínas de fusão e dimérica, usos das mesmas e composição farmacêutica |
| MX2021001493A (es) | 2018-08-06 | 2021-07-15 | Medikine Inc | Compuestos de fijación al receptor de il-2. |
| KR20220110207A (ko) | 2019-11-05 | 2022-08-05 | 메디카인 인코포레이티드 | IL-2RβγC 결합 화합물 |
| MX2022005404A (es) * | 2019-11-05 | 2022-09-09 | Medikine Inc | Compuestos de fijación a il-2r e il-7r dual. |
| JP2023512687A (ja) | 2020-02-03 | 2023-03-28 | メディカイン、インコーポレイテッド | ＩＬ－７Ｒα結合化合物 |
| IL295304A (en) | 2020-02-03 | 2022-10-01 | Medikine Inc | Il-7 receptor alpha gamma c binding compounds, compositions comprising same and uses thereof |
-
2020
- 2020-11-04 MX MX2022005404A patent/MX2022005404A/es unknown
- 2020-11-04 BR BR112022008750A patent/BR112022008750A2/pt not_active IP Right Cessation
- 2020-11-04 CA CA3160466A patent/CA3160466A1/en active Pending
- 2020-11-04 WO PCT/US2020/058969 patent/WO2021092081A1/en not_active Ceased
- 2020-11-04 KR KR1020227018973A patent/KR20220110209A/ko not_active Withdrawn
- 2020-11-04 AU AU2020378282A patent/AU2020378282B2/en active Active
- 2020-11-04 US US17/089,533 patent/US11248030B2/en not_active Expired - Fee Related
- 2020-11-04 IL IL292803A patent/IL292803A/en unknown
- 2020-11-04 EP EP20884174.2A patent/EP4055036A4/en not_active Withdrawn
- 2020-11-04 JP JP2022525813A patent/JP7427287B2/ja active Active
- 2020-11-05 TW TW109138624A patent/TW202132330A/zh unknown
-
2022
- 2022-01-04 US US17/568,411 patent/US20220119465A1/en not_active Abandoned
-
2023
- 2023-08-10 AU AU2023214299A patent/AU2023214299A1/en not_active Abandoned
-
2024
- 2024-01-17 JP JP2024005177A patent/JP2024056696A/ja not_active Withdrawn